Atlas Trials

A Study to Assess the Effect of AZD5634 on Mucociliary Clearance, Safety, Tolerability and Pharmacokinetic Parameters in Patients With Cystic Fibrosis

Clinical trial NCT02950805 · COMPLETED

Trial details

NCT number
NCT02950805
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary/Respiratory Diseases
Start date
2017-05-30
Primary completion
2018-04-12
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.